Search
Search
Editorially independent content, supported with advertising
08.24.23
On this episode of “Survey Says” With I. Paul Singh, MD, a special edition of GT: The Podcast, Dr. Singh is joined by guests Oluwatosin Smith, MD, and Jason Bacharach, MD. The panel delves into the benefits and challenges of having a wide array of treatment options for glaucoma and how they approach decisions about surgical intervention. Later, they weigh in on the case in question, offering their thoughts on the target IOP and treatment goals for a patient with moderate primary open-angle glaucoma. Then, they review how their colleagues would proceed based on results of a social media poll of Glaucoma Today’s audience.
06.26.25
Survey Says: Choosing Treatment for a High-Risk PatientI. Paul Singh, MD; Erin Sieck, MD; and Arkadiy Yadgarov, MD
03.19.25
Survey Says: Proceeding After Unsuccessful TreatmentI. Paul Singh, MD; Manjool Shah, MD; and Ticiana De Francesco, MD,
12.19.24
Survey Says: Treatment for a High-Risk PatientPaul Singh, MD; Lorraine M. Provencher, MD; and Brian Shafer, MD
09.19.24
Survey Says: Next Steps for Slowly Progressive DiseaseI. Paul Singh, MD; Monica Ertel, MD; and Mark Gallardo, MD
05.28.24
Survey Says: Fluctuating IOP and Poor ComplianceI. Paul Singh, MD; Jella An, MD, MBA; and John Berdahl, MD
01.18.24
Survey Says: Which Treatment Next?I. Paul Singh, MD; Zarmeena Vendal, MD; and Joseph F. Panarelli, MD
08.24.23
Survey Says: Target IOP and Next StepsI. Paul Singh, MD; Oluwatosin Smith, MD; and Jason Bacharach, MD
12.14.22
Survey Says: Procedure and IOL SelectionI. Paul Singh, MD; Shamil Patel, MD, MBA; and Manjool Shah, MD
09.13.22
Survey Says: Determining Target IOP and Next StepsI. Paul Singh, MD; Analisa Arosemena MD; and Lorraine Provencher, MD
06.15.22
‘Survey Says’ With I. Paul Singh, MDI. Paul Singh, MD; Deborah Ristvedt, DO; and Shamik Bafna, MD
